CNR1 and irritable bowel syndrome: Numerous studies have shown that activation of CB1/CB2 receptors in CB1-deficient protects against experimental colitis in mice (27–29) in contrast to CB1-, CB2- deficient mice which had more severe IBD course than wild-type mice with induced inflammation.